Rosemary Zuna to Disease-Free Survival
This is a "connection" page, showing publications Rosemary Zuna has written about Disease-Free Survival.
Connection Strength
0.053
-
A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol. 2014 Jun; 133(3):537-41.
Score: 0.027
-
The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):377-82.
Score: 0.026